Ceramide derivatives as modulators of immunity and autoimmunity

Details for Australian Patent Application No. 2005280163 (hide)

Owner Albert Einstein College of Medicine of Yeshiva University

Inventors Porcelli, Steven A.

Agent Spruson & Ferguson

Pub. Number AU-B-2005280163

PCT Pub. Number WO2006/026389

Priority 60/605,362 27.08.04 US

Filing date 26 August 2005

Wipo publication date 9 March 2006

Acceptance publication date 24 November 2011

International Classifications

C07H 15/06 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

A61K 31/7028 (2006.01) - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages

A61K 31/715 (2006.01) - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

C07H 15/10 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07H 15/18 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/026389 Priority application(s): WO2006/026389

24 November 2011 Application Accepted

  Published as AU-B-2005280163

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005280167-Pyrimidinylpyrazoles as TGF-beta inhibitors

2005280162-Single-primer nucleic acid amplification methods